key: cord-0813892-zamn9kc0
authors: Jakeman, Ms Molly; Khaw, Ms Rong; Zack-Williams, Mr Shomari; Brackley, Mr Philip
title: Implementation of a telemedicine service to provide skin cancer care in a tertiary plastic surgery unit during COVID-19- a comprehensive review.
date: 2022-04-25
journal: J Plast Reconstr Aesthet Surg
DOI: 10.1016/j.bjps.2022.04.031
sha: 5d888e3d1ef84b9dcd5bd1a7ba1b26d052d5aeaa
doc_id: 813892
cord_uid: zamn9kc0

BACKGROUND: : In response to the COVID-19 pandemic, our tertiary skin cancer service had to adapt rapidly to reduce hospital footfall. Consequently, all clinic appointments for skin cancer patients were converted to telephone consultations. This study aims to provide a comprehensive review of this new service. METHODS: : This study consisted of three domains; patient and staff experience, efficacy and productivity. Patient and staff experience was assessed through prospective surveys. Efficacy of telephone appointments was assessed through prospective review of clinic coding to evaluate outcomes including rate of conversion to face-to-face appointment. Markers of treatment pathway efficacy included time from referral to surgical listing and the incidence of benign lesions placed on skin cancer pathways. Productivity was evaluated through review of the cumulative number of completed and missed appointments over a one-month period before and during the pandemic. RESULTS: : All patients were satisfied with the telephone consultation and were preferred to previous experience of face-to-face appointments by 67%. Over 80% of responding clinicians felt telephone clinics should remain as a legacy of COVID-19. Time from referral to scheduling for surgery was significantly shorter for urgent lesions when listed through a teleclinic compared to face-to-face appointment. The telephone service allowed us to maintain 46% of the Plastic Surgery outpatient activity of May 2019 and missed appointments almost halved. CONCLUSION: : Patients and clinicians have responded positively to the new service. This study highlights the merits of an ongoing telephone clinic service for select patients on resolution of the COVID-19 impact on health services.

The COVID-19 pandemic has placed a huge burden on hospital services worldwide. In March 2020, NHS England issued guidance to all hospital trusts to suspend elective services in preparation for an expected surge in hospital admissions from COVID-19 infection. 1 In addition, the U.K. government issued instructions calling for strict social distancing practices and introduced shielding for those deemed 'Clinically Extremely Vulnerable'. 2 As a consequence, hospital services had to re-evaluate how to provide safe and effective patient care within these new constraints. 3 Our service is the supraregional Plastic Surgery Centre for the Northwest of England and North Wales with a catchment of approximately five million people. This includes the regional centre for Mohs Surgery and a tertiary skin cancer service for melanoma. In our unit, all clinic appointments for skin cancer patients were converted to telephone consultations in order to reduce hospital footfall, potential viral exposure to patients and the number of consultation rooms and staff involved. Telephone consultations ensured timely assessment of new patient referrals and follow-up reviews for skin cancer patients were maintained. One clinic session per week was reserved for face-to-face appointments catering for those identified as having disease progression requiring urgent review or whose needs were not met over the telephone.

The aim of this study was to assess the impact of this unavoidable, large-scale service restructuring in three domains; patient and staff experience, efficacy and productivity.

1. Experience-opinions of the new service by both staff and patient were sought.

2. Efficacy-indicators of efficacy of the service included: a. Outcome of telemedicine clinic appointments to evaluate the proportion of patients that were able to progress through their management pathway as a result of their appointment.

b. Review of surgical management pathways following a decision made through the telemedicine service. Markers included appropriate use of skin cancer treatment pathways, time from initial referral to both surgical listing in clinic and date of surgery.

3. Productivity-indicators of productivity of the service included: a. Volume of appointments undertaken b. Incidence of "missed" appointments c. Duration of telemedicine appointments At the instructed cessation of elective services, our department did not have an established video appointment service. Although in trial at this time, they were not in widespread use and therefore excluded from this study. This study includes telephone consultations with the adjunct of a secure system for photographic images. Images were provided either by the referrer or sent by the patient during the appointment.

A prospective survey consisting of a 12-item questionnaire was conducted from 21 st September to 2 nd October 2020 targeting patients who attended the minor surgery unit for elective surgical treatment of suspected skin cancer. Only patients who had received a telephone consultation from our service were included in the study. The questionnaire surveyed the ease-of-use, interaction quality, satisfaction and patients' view to future use of telephone services. Open-ended questions on strengths and weaknesses of telephone consultations were used to evaluate patients' opinions. Thematic analysis was performed for open-ended questions. 

Prospective evaluation of telephone clinic outcome codes was undertaken over a two-week period. Positive indicators that patients were progressing along their treatment pathway included the scheduling of surgery and discharge to primary care. A negative indicator was the conversion to a face-to-face appointment as a result of their needs not being met by the telephone appointment.

Surgical treatment pathways were reviewed for 55 consecutive non-pigmented lesions biopsied in May 2020 from patients who were listed for surgical excision through a telephone consultation. Lesions were included if they were suspected to be malignant and placed on a cancer treatment pathway. Our two treatment pathways are "urgent" for suspected melanoma or cutaneous squamous cell carcinoma (SCC) and "semi-urgent'' for suspected basal cell carcinoma (BCC) with target treatment times of 31 days and 90 days, respectively.

Pigmented lesions were excluded as our department infrequently undertook diagnostic biopsies of pigmented lesions prior to the pandemic. During the pandemic, we experienced a rise in Dermatology assessed pigmented lesions for biopsy due limitations on their capacity.

Histology results were reviewed to assess diagnostic concordance and the appropriate use of urgent and semi-urgent surgical pathways. Furthermore, the time from initial referral to both scheduling for surgery and date of surgery was reviewed.

Retrospective analysis was undertaken of the number of completed and missed appointments throughout May 2020. These figures were compared against the pre-pandemic face-to-face outpatient service in May 2019. 'Missed' telemedicine appointments were coded for failed patient contact during the clinic session.

Prospective evaluation of surgeon-reported appointment timings was undertaken over a twoweek period.

Statistical analysis was conducted using StatsDirect v3 software (StatsDirect Ltd., Merseyside, U.K.). Categorical variables were compared utilising a Chi Squared Test. Where expected frequencies were too small for quared, Fisher's exact test was used. Continuous, parametric data was compared using unpaired t-test and Mann-Whitney U test if nonparametric. Statistical significance was defined as a p-value <0.05. Table 1 )

Fifty-eight individual responses were collected during the two-week period yielding a 74% response rate. Fifteen patients reported that they did not receive a telephone consultation prior to surgery were excluded from the study 70% of patients rated their telephone clinic appointment as 'excellent', 25% as 'good' and the remaining 5% rated the appointment as 'fair'. 68% of patients were (1) very satisfied with their telephone clinic appointment and (2) reported that the teleconsultation was extremely effective in dealing with their respective health concern. 80% of patients responded that they definitely received the kind of service they expected during their teleconsultation and 77% of patients responded that almost all their needs were attended to. All patients reported that they would both be happy to have another telephone appointment if they had a similar problem in the future and recommend the department's telemedicine service to their friends and family.

When asked whether they preferred the telephone appointment to a face-to-face appointment, 67% responded positively, 31% preferred the latter and 2% remained neutral. 63% of respondents gave reasons for preferring a telephone appointment including less time spent on travel (n=18), time saved off work (n=9) and reduced impact on family commitments (n=6).

Eleven patients provided reasons for opting against telephone consultations including concerns over the clinician's inability to visualise the skin lesion over the telephone (n=7) and the adequacy for long term monitoring for patients with high-risk skin cancers (n=1). Table 2) A 53% (n=26/49) staff response rate was achieved with an even distribution of respondents from all grades (10 consultants, 7 specialty registrars, 9 trust grade registrars). The majority of doctors (n=15) conduct 1-2 half-day sessions of telephone clinics for skin cancer per week.

Four registrars reported undertaking 3-5 sessions of telephone clinics per week during the pandemic.

Most doctors reported using an average 10-15mins (n=12) or more than 15 mins (n=10) for each new patient referral over the telephone. A similar time was spent over the telephone with follow-up appointments; 42% (n=11) spent 10-15mins and 23% (n=6) spent 7-10mins.

81% of doctors agreed that telephone consultations should be a regular feature of the department's skin cancer service post-pandemic but only 65% felt that it is cost effective.

Only 58% reported that teleconsultation was effective in dealing with their patients' concerns. Most doctors (81%) felt that further training in risk management and consultation skills are needed if the telemedicine service is made permanent.

In the thematic analysis of the free-text, 20 out of 26 individuals voiced concerns regarding the suitability of teleclinics for disabled and vulnerable patient groups and the inability to physically examine patients. Reported advantages included that the service is COVID safe (n=8), convenient for both patients (n=5) and staff (n=3) and an effective mode of consultation for a selected cohort of patients who are technologically competent and possess a low-risk skin cancer profile (n=12).

During the two-week observation period, 258 telemedicine consultations were undertaken, comprising 210 follow-up (81%) and 48 (19%) new appointments. The majority of patients (n=111; 43%) continued on standard skin cancer follow-up pathways, 65 (25%) of patients were added to the waiting list for surgery, 60 (23%) were successfully discharged back to primary care and 9 (3.5%) were referred onto another hospital speciality. Conversion to faceto-face appointment was required in 12 (4.7%) cases. Table 3 )

Patient age was comparable between the two groups (72 years in 2019 vs. 74 years in 2020).

In 2019, histology proved 62% of excised lesions were malignant, 18% pre-malignant or in situ disease and 20% benign. The most commonly excised lesion was a BCC (49%) and clinical and histopathological concordance was 67%. Referrals were predominantly from primary care (51%). In 2020, histology proved 75% of lesions were malignant, 11% were pre-malignant or in situ disease and 15% were benign. The most commonly excised lesion was SCC (47%). Clinical and histopathological concordance was 73%. Referrals were predominantly from Dermatology (60%). Although listed for surgery through a telephone appointment, 64% had a prior face-to-face consultation with Dermatology and 26% with their general practitioner.

The proportion of patients on the urgent cancer pathway was larger in 2020 (27% in 2019 vs. 90% in 2020). For newly referred skin lesions, mean time from initial referral to surgical scheduling for lesions subsequently placed on the urgent surgical pathway was significantly shorter in 2020 (19 days in 2019 vs. 12 days in 2020; p=0.01). Fewer days from initial referral to date of surgery was demonstrated for these lesions but this fell short of statistical significance (35 days vs. 27 days in 2020, p=0.06). A trend of shorter time from initial referral to both surgical scheduling and date of surgery was found for semi-urgent pathway but this did not meet statistical significance.

In both 2019 and 2020, there were no instances of histologically proven urgent malignancies on the semi-urgent pathway and all but one patient received treatment within the target times.

This patient was on the semi-urgent pathway in 2019 and chose to have surgery one week later than the target time. There was no statistical difference in the incidence of histologically proven benign lesions between the two groups.

In May 2020, 1,581 (494 new and 1,087 follow-up) appointments were scheduled. This equates to 46% of appointments scheduled under "normal" circumstances in May 2019.

These appointments represent the entirety of the plastic surgery outpatient service (excluding trauma) in May 2020, as all other non-urgent, subspecialty services were suspended except for the new telemedicine skin cancer service. There were 74 (4.5%) missed appointments in May 2020 compared to 298 (7.8%) 'DNA's in May 2019.

Prospective evaluation of 132 telephone consultations was undertaken. Average duration of new patient appointments was longer than for follow up (8 minutes 48 seconds vs. 6 mins 29 seconds). During the observation period, 11 patients required a second phone consultation within the same clinic session in order to complete the appointment.

Telemedicine services and technological adjuncts to face-to-face consultations have been in place long before the COVID-19 pandemic. A systematic review of the use of telemedicine in Plastic Surgery services demonstrated its application in trauma assessment, burns care, wound management and post-operative monitoring. 4 Telemedicine services have many advantages including patient convenience, reduction in travel time, reduction in the number of clinic visits, reduced costs and increased access to those living in rural areas. 4 Our study has demonstrated high levels of patient satisfaction with the telephone service.

Positive patient experience with telemedicine services has reported in both Plastic Surgery and Dermatology prior to the pandemic. [6] [7] [8] [9] Patient satisfaction has been reported in the context of post-operative evaluation both over video 8 and telephone consultation. 7 A singleinstitution review of telehealth services found significantly higher patient satisfaction scores across all consultations (face-to-face and video) during the pandemic compared to the pre-COVID period. 10 This is likely due to change in patient expectation as a result of the wellpublicised impact on healthcare services and highlights the importance of ongoing evaluation.

There is less literature on the perceptions of the healthcare provider on telemedicine. A recent survey of aesthetic consultant surgeons found that 64% would use video consultations for pre-and post-operative assessments. 11 A recent survey of 1,250 U.K. doctors found that 70% of respondents have seen benefits of telemedicine during the pandemic. However, 76% are worried about missing something and 60% are more worried about a claim or investigation arising. 12 Interestingly, surgeons surveyed in our study reported much longer consultation times compared to our prospective evaluation. In addition, we found mixed opinions regarding the effectiveness of dealing with patients over the phone. However, we found the incidence of both second phone consultations and conversion to face-face-appointments was low. The majority (81%) of our respondents felt they needed further training in risk management and consultation skills specific to telephone clinics. These findings suggest that there is further work required to investigate these concerns and support clinicians unfamiliar with telemedicine. Recent GMC guidance and educational modules on remote consultations from indemnity providers is starting to address this demand. 5, 12 In contrast to previously published papers, our study found an increase in the rate of diagnostic concordance for suspected skin cancer when listed through a teleclinic. 13, 14 In addition, our rate of suspected cancer that was proven benign on biopsy was lower when listed through our teleclinic service compared to the "normal" face-to-face service. This is almost certainly a reflection of selection bias, with a higher level of suspicion for lesions referred during the pandemic by the patient and the referrer. In general, the literature reports higher skin cancer diagnostic concordance with face-to-face consultation than with telemedicine. However, inconsistencies in study methodologies limit accurate comparison and some authors have reported high levels of accuracy with diagnoses made over telemedicine services. 13 The adjunct of teledermoscopy appears to improve diagnostic accuracy but requires both clinician and patient education to be effective. 14 Rather than a high rate of diagnostic concordance, we would argue that a low rate of benign lesions excised on the urgent cancer pathway in combination with maintaining cancer treatment target times is a more accurate marker of service efficacy. Efficient use of operating capacity is even more important in the context of the pandemic where it has and continues to be significantly reduced.

Studies have demonstrated that the time from referral to treatment is shorter when telemedicine services are used in both Plastic Surgery trauma services 15 and Mohs Surgery. 16 Our study found a significantly shorter time from initial referral to surgical scheduling for urgent lesions during our teleclinic service compared to "normal" service. We also found a shorter time from initial referral to surgery but this fell just short of statistical significance.

The ability to assess patients and initiate treatment on the urgent cancer pathway sooner demonstrates a significant advantage of the new service.

The COVID-19 pandemic has forced us to work differently in order to continue to provide patient care. Despite this there has been a significant fall in the number of skin cancer diagnoses during the pandemic. [17] [18] [19] [20] The reasons for this are not clear and are likely to include multiple factors such as patient fear or reluctance to seek advice and difficulties (or perceived difficulties) in accessing care. As a consequence, there is an expected surge in skin cancer diagnoses as the impact of the pandemic on medical services is reduced and services will have to adapt again to manage this increased demand. There are positive findings from this study to support the ongoing use of a telephone clinic service. We would advocate the ongoing use of a telephone-based service in conjunction with a secure photography referral system and robust triage and safeguarding processes, in the following circumstances: The reduced burden on our hospital services as a result of the pandemic has allowed us to move to a "hybrid" outpatient model. Consultant-led outpatient clinics have been reinstated with templates adapted to consist of both face-to-face and telephone appointments. Ongoing evaluation of telemedicine services across specialities from the perspectives of both the patient and surgeon in addition to service efficacy is required as we enter the post-COVID era.

Not applicable.

Written consent for survey result publication was obtain from all patients involved. (3) 56% (5) 11% (1) 43% (3) 14% (1) 42% (3) 3. On average how long does it take you to finish a telephone consultation for a new referral? 40% (4) 30% (3) 10% (1) 33% (3) 56% (5) 11% ( 

Letter to chief executives of all NHS trusts and foundation trusts, CCG accountable officers, GP practices and primary care networks, and providers of community health services

Department of Health and Social Care & Public Health England. Guidance on Shielding and Protecting Extremely Vulnerable Person from COVID-19

Covid-19: Plastic and reconstructive surgery escalation policy

A Systematic Review of the Use of Telemedicine in Plastic and Reconstructive Surgery and Dermatology

Patient satisfaction with a new skin cancer teledermatology service

Outpatient ophthalmic plastic surgery: outcomes and patient satisfaction using initial postoperative telephone call follow-up

Innovations in the Plastic Surgery Care Pathway: Using Telemedicine for Clinical Efficiency and Patient Satisfaction

Diagnostic accuracy of and patient satisfaction with telemedicine for the follow-up of paediatric burns patients

Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study

COVID-19 Reducing the Risks: Telemedicine is the New Norm for Surgical Consultations and Communications

Medical Protection Society. 4 in 5 doctors concerned some patients will get left behind if telemedicine increases post COVID-19

Teledermatology for diagnosing skin cancer in adults

Teledermatology for the diagnosis and management of skin cancer: a systematic review

Plastic surgery telehealth consultation expedites Emergency Department treatment

Teledermatology as a Tool for Preoperative Consultation Before Mohs Micrographic Surgery Within the Veterans Health Administration

The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons

Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic

Major fall in urgent skin cancer referrals during the COVID-19 outbreak

Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic

None